VITA Magazine » COMMUNITAS » Yalla Italia! » SUBSCRIBE TO OUR NEWSLETTER »

Article written

  • on 07.05.2014
  • at 05:00 PM
  • by Kevin Hind

EU approves US$947 million for African clinical trials 0

Cape Town – The European Council has approved a 683 million euro (US$947 million) budget proposal for the second phase of the European and Developing Countries Clinical Trials Partnership (EDCTP2) to boost medical research in Sub-Saharan Africa.


The new budget passed by the council of the European Commission today (May 6) triples that of the first phase (2003-2015) which was US$278 million. The new funding is part of Horizon 2020, the EU Framework Programme for Research and Innovation (2014-2020).

The European Parliament approved the proposed budget with overwhelming majority of 646 out of 671 votes last month (15 April) and was awaiting the council’s vote.

The EDCTP works to establish and strengthen research capacity in 48 countries in Sub-Saharan Africa to accelerate clinical trials to produce new drugs for combating HIV/AIDS,malaria and tuberculosis in Sub-Saharan African.

Charles Mgone, EDCTP executive director, says more funding will translate into more support for a larger number of projects and clinical trials.

“This action reflects the importance that the European Union attaches to its partnership with Africa and to the fight against poverty-related diseases as well as recognition of the very tangible results of the first EDCTP programme as an instrument for achieving these aims,” he says.

continue reading on SciDev Net

By Munyaradzi MakoniSciDev Net 

subscribe to comments RSS

Comments are closed

Project by VITA SOCIETÀ EDITORIALE S.P.A.
P.IVA 11273390150
ISCRIZIONE ROC N.3275
Direttore Responsabile afronline.org: Giuseppe Frangi
©2011-2015